NCT01330485

Brief Summary

The primary aim of the study is to evaluate the efficacy of a systematic training of general affect regulation skills (ART) on the reduction of depressive symptom in individuals meeting criteria for major depressive disorder (MDD).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
218

participants targeted

Target at P75+ for not_applicable major-depressive-disorder

Timeline
Completed

Started Nov 2010

Typical duration for not_applicable major-depressive-disorder

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2010

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 4, 2011

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 7, 2011

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2014

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
Last Updated

April 10, 2019

Status Verified

April 1, 2019

Enrollment Period

3.4 years

First QC Date

April 4, 2011

Last Update Submit

April 8, 2019

Conditions

Keywords

depressionemotion regulationaffect regulationskillsrandomized controlled trialmediation

Outcome Measures

Primary Outcomes (1)

  • Change in depressive symptoms

    Change in depressive symptoms as assessed in Beck Depression Inventory (BDI-II) and Hamilton Rating Scale for Depression (HRSD) and aggregated to a composite score is possible

    Pre to post ART, CFC or WLC; hence covering the ten week time period from the first assessment point (prior to randomization) to the assessment point 10 weeks later

Secondary Outcomes (1)

  • Emotion regulation skills

    Pre to post ART, CFC or WLC; hence covering the ten week time period from the first assessment point (prior to randomization) to the assessment point 10 weeks later

Other Outcomes (2)

  • General psychopathological symptom load

    Pre to post ART, CFC or WLC; hence covering the ten week time period from the first assessment point (prior to randomization) to the assessment point 10 weeks later

  • Course of depressive symptoms during individual CBT after ART/CFC/WLC.

    Pre to post individual CBT (estimated up to 2 years, depending upon the patient's specific needs)

Study Arms (3)

Affect Regulation Training

EXPERIMENTAL

Affect Regulation Training as described in Berking \& Whitley, 2014.

Behavioral: Affect Regulation Training

Common Factor Control Condition (CFC)

ACTIVE COMPARATOR

Common factor based therapy control condition

Behavioral: Common Factor Control Condition

Waitlist Control Condition

NO INTERVENTION

Wait List Control

Interventions

The ART is a transdiagnostic, group-based intervention that has been developed to explicitly target emotion regulation skills (e.g., the abilities to be aware of, understand, accept, tolerate and modify negative emotions).

Also known as: ART
Affect Regulation Training

The CFC is an active treatment condition designed to control for unspecific effects of psychotherapeutic interventions.

Also known as: CFC
Common Factor Control Condition (CFC)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of MDD according to DSM-IV criteria as the primary diagnosis
  • age 18 and above
  • sufficient German language skills

You may not qualify if:

  • high risk of suicide
  • indication of substantial secondary gain
  • currently in psychotherapeutic treatment with an institution/professional other than those involved in the study
  • co-occurring psychotic, bi-polar, and/or substance disorders
  • organic brain disorder(s), severe medical condition, and/or severe cognitive impairment that impedes ability to participate in the study or treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Philipps-University of Marburg

Marburg, Hesse, 35032, Germany

Location

Aus- und Weiterbildungszentrum für Klinische Verhaltenstherapie

Kassel, 34119, Germany

Location

University of Mainz

Mainz, D-55122, Germany

Location

Related Publications (3)

  • Eichler E, Hager M, Baeuml J, Berking M. Emotion regulation as mechanism of change in the treatment of depression - A latent change score analysis. J Affect Disord. 2026 Jan 1;392:120205. doi: 10.1016/j.jad.2025.120205. Epub 2025 Sep 2.

  • Berking M, Eichler E, Luhmann M, Diedrich A, Hiller W, Rief W. Affect regulation training reduces symptom severity in depression - A randomized controlled trial. PLoS One. 2019 Aug 29;14(8):e0220436. doi: 10.1371/journal.pone.0220436. eCollection 2019.

  • Ehret AM, Kowalsky J, Rief W, Hiller W, Berking M. Reducing symptoms of major depressive disorder through a systematic training of general emotion regulation skills: protocol of a randomized controlled trial. BMC Psychiatry. 2014 Jan 27;14:20. doi: 10.1186/1471-244X-14-20.

MeSH Terms

Conditions

Depressive Disorder, MajorDepressionEmotional RegulationNegotiating

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental DisordersBehavioral SymptomsBehaviorSelf-ControlSocial BehaviorCommunication

Study Officials

  • Matthias Berking, Prof. Dr.

    Friedrich-Alexander-University Erlangen-Nuremberg

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Assessors were blinded to study conditions.
Purpose
TREATMENT
Intervention Model
FACTORIAL
Model Details: Group (3 groups) x time
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr.

Study Record Dates

First Submitted

April 4, 2011

First Posted

April 7, 2011

Study Start

November 1, 2010

Primary Completion

April 1, 2014

Study Completion

September 1, 2014

Last Updated

April 10, 2019

Record last verified: 2019-04

Data Sharing

IPD Sharing
Will share

Deidentified IPD will be made available to other researchers upon reguest.

Shared Documents
ICF, ANALYTIC CODE
Time Frame
From January 2018 to January 2028
Access Criteria
Credible and legitimate reason for request

Available IPD Datasets

Individual Participant Data Set Access
All study files Access

Locations